Publications

Trump’s FTC Continues The Mission Of Eliminating Orange Book’s Improper Patent Listings

Quoted, Generics Bulletin

Chad Landmon, Hatch-Waxman & Biologics Chair, discusses how the Federal Circuit is weighing in on Orange Book patent listings.